Pharmaceutical

Nuclear Medicine Titans: The Battle in a $10 Billion Market Bayer Novatis AstraZeneca BMS Eli Lilly Explore how pharma giants like Novartis, Bayer, AstraZeneca, BMS, and Eli Lilly are battling for dominance in the booming $10B radiopharmaceutical market with cutting-edge therapies and strategic acquisitions.
Gene Therapy IND Overview (Jan-Mar) 2025 Market Trend Hengrui A comprehensive overview of global gene therapy IND approvals from January to March 2025, highlighting breakthroughs in rare diseases, neurological disorders, and innovative delivery platforms.
mRNA Vaccine Progress Review (January–March) 2025 Market Trend mRNA Roche CSPC Explore key mRNA vaccine developments from Jan–Mar 2025, covering breakthroughs in cancer, flu, herpes zoster, and tuberculosis prevention and treatment globally.
Top 10 Best-Selling Drugs Globally in 2024 Market Trend Discover the top 10 best-selling drugs globally in 2024, including Keytruda, Ozempic, and Biktarvy. Learn about their sales, market trends, and upcoming challenges in this detailed breakdown of the pharmaceutical industry's biggest earners.
Top 10 CEO Salaries in the Pharmaceutical Industry Market Trend Discover the top 10 highest-paid pharmaceutical CEOs in 2024, with salaries reaching nearly $300 million. Learn about their earnings, stock options, and the financial performance of major pharma companies like BioNTech, Eli Lilly, Pfizer, and Moderna.
Iovance Biotherapeutics 2024 Financial report Financial statements 2024 Financial Report Iovance Biotherapeutics Iovance Biotherapeutics reports 2024 revenue of $164 million, with its TIL therapy Amtagvi (Lifileucel) generating $103.6 million in sales. The company expects 2025 revenue of $450M to $475M.
WuXi AppTec's 2024 Financial report Financial statements WuXi AppTec 2024 Financial Report WuXi AppTec's 2024 report reveals a 47% year-on-year increase in orders, with revenue at RMB 39.24 billion. The company expects growth in 2025, alongside special dividends and an A-share buyback plan.
Bayer's 2024 Financial report Financial statements Bayer Bayer's 2024 financial report reveals a 2.2% revenue decline, 6,908 job cuts, and ongoing legal battles. With strategic shifts and heavy R&D investment, the company faces challenges and opportunities ahead. Can Bayer turn the tide by 2025?
2024 Global Top 10 Pharmaceutical Companies Market Trend Pfizer Merck AbbVie AstraZeneca Roche Novartis Eli Lilly Sanofi The 2024 global ranking of the top 10 pharmaceutical companies showcases the continued strength of industry leaders like Johnson & Johnson, Roche, and Merck. Pfizer, AstraZeneca, and Eli Lilly also maintain strong positions with impressive growth and strategic investments.
The Global Vaccine Market: How Pfizer, Merck, GSK & Sanofi Maintain Their Dominance Market Trend Pfizer Merck GSK Sanofi Vaccine As the pandemic subsides, the industry is returning to pre-pandemic dynamics, with Pfizer strengthening its pneumonia vaccine leadership, Merck betting on HPV and RSV, GSK focusing on meningitis, and Sanofi expanding its RSV monoclonal antibody business.

< Pre 1...55 56 575859 60 61...87 Next >

Articles Archives

Hot Articles

Related Exhibition

All Categories

Agri & Industry Cosmetic Food History Laboratory

HOT Topics

Hot Articles